Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Esperion Therapeutics, Inc. (ESPR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in ESPERION THERAPEUTICS INC |
| 02/14/2023 |
SC 13G/A
| CVI Investments, Inc. reports a 6.9% stake in Esperion Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| WASATCH ADVISORS INC reports a 12.8% stake in Esperion Therapeutics, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.8% stake in Esperion Therapeutics Inc. |
| 01/04/2023 |
SC 13G/A
| Meditor Group Ltd reports a 6.1% stake in Esperion Therapeutics, Inc. |
| 05/17/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| CVI Investments, Inc. reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.1% stake in Esperion Therapeutics Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/12/2022 |
SC 13G/A
| Meditor Group Ltd reports a 7.1% stake in Esperion Therapeutics, Inc. |
| 01/10/2022 |
SC 13G/A
| BlackRock Inc. reports a 3.6% stake in ESPERION THERAPEUTICS INC |
| 05/28/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/06/2021 |
SC 13G/A
| Meditor Group Ltd reports a 9.6% stake in Esperion Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in ESPERION THERAPEUTICS INC |
| 01/06/2020 |
SC 13G/A
| Meditor Group Ltd reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/03/2019 |
SC 13G/A
| Meditor Group Ltd reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 10/30/2018 |
SC 13G/A
| Boxer Capital, LLC reports a 10.3% stake in ESPERION THERAPEUTICS, INC. |
|
|
|